SAN FRANCISCO, June 11, 2021 /PRNewswire/ — Invitae (NYSE: NVTA), a number one medical genetics firm, at this time introduced the appointment of Roxi Wen as its chief monetary officer, efficient June 21, 2021. Wen brings many years of success as a senior monetary government the place she scaled international expertise and medical expertise corporations.

“We’re delighted Roxi might be becoming a member of our crew. Her observe document of driving development, monetary administration and execution of distinctive enterprise fashions within the U.S. and worldwide markets throughout expertise and life science settings is effectively suited to our objectives,” stated Sean George, Ph.D., co-founder and chief government officer of Invitae. “Along with her experience, Roxi shares our crew’s ardour to ship genetic info bettering healthcare for sufferers worldwide.”

Wen involves Invitae from Mozilla Company, the place she served as CFO for the previous two years, main a change protecting all points of the enterprise, driving capital allocation, constructing analytics functionality, restoring profitability and main income diversification. In that function, she oversaw finance and accounting, M&A, enterprise growth, knowledge and analytics, IT and engineering operations, office assets, and sustainability. Previous to Mozilla, Wen served in CFO roles at Elo Contact Options, a worldwide innovator and chief in contact display screen techniques, and Normal Electrical Vital Energy following expertise driving capital market and enterprise finance efforts at Medtronic, a number one medical expertise firm. Roxi is a CFA charterholder and has a MBA from the College of Minnesota.

As beforehand introduced, Shelly D. Guyer, Invitae’s present chief monetary officer, will now focus full-time on the corporate’s Surroundings, Social and Governance (ESG) efforts, which had been detailed within the publication of Invitae’s first-ever ESG Annual Report in March 2021.

“Shelly has been instrumental in Invitae’s development as she led us by way of a tenfold enhance in income, from an organization valuation of $400 million to over $6 billion, whereas elevating over $3 billion of capital within the course of to gasoline our capacity to realize our most essential marker of success: rising from serving to tens of 1000’s of sufferers to over 2 million as of some weeks in the past,” stated Dr. George. “With Roxi’s arrival, Shelly will now shift to focus solely on main our ESG efforts, a central precedence for Invitae, our crew, our clients and our buyers.  She has lengthy been desirous about amplifying our ESG efforts, and I am happy this essential effort is in her succesful palms.”

About Invitae

Invitae Company (NYSE: NVTA) is a number one medical genetics firm whose mission is to deliver complete genetic info into mainstream drugs to enhance healthcare for billions of individuals. Invitae’s objective is to mixture the world’s genetic checks right into a single service with increased high quality, sooner turnaround time, and decrease costs. For extra info, go to the corporate’s web site at

Secure Harbor Assertion

This press launch incorporates forward-looking statements inside the that means of the Personal Securities Litigation Reform Act of 1995, together with statements referring to the appointment of Roxi Wen as the corporate’s new chief monetary officer and Shelly Guyer’s give attention to main the corporate’s ESG efforts. Ahead-looking statements are topic to dangers and uncertainties that would trigger precise outcomes to vary materially, and reported outcomes shouldn’t be thought of as a sign of future efficiency. These dangers and uncertainties embrace, however usually are not restricted to:  the corporate’s historical past of losses; the corporate’s capacity to compete; the corporate’s failure to handle development successfully; the corporate’s have to scale its infrastructure prematurely of demand for its checks and to extend demand for its checks; the corporate’s capacity to make use of quickly altering genetic knowledge to interpret check outcomes precisely and persistently; safety breaches, lack of knowledge and different disruptions; legal guidelines and laws relevant to the corporate’s enterprise; and the opposite dangers set forth within the firm’s filings with the Securities and Trade Fee, together with the dangers set forth within the firm’s Quarterly Report on Kind 10-Q for the quarter ended March 31, 2021. These forward-looking statements communicate solely as of the date hereof, and Invitae Company disclaims any obligation to replace these forward-looking statements. 

Contact for Invitae:
Laura D’Angelo
[email protected]
(628) 213-3369

SOURCE Invitae Company

Associated Hyperlinks

Source link